onr:"swepub:oai:DiVA.org:liu-77658"
Search: onr:"swepub:oai:DiVA.org:liu-77658" > PT-141 Palatin.
- 1 of 1
- Previous record
- Next record
- To hitlist
PT-141 Palatin.
-
- Hedlund, Petter (author)
- Linköpings universitet,Klinisk farmakologi,Hälsouniversitetet
- (creator_code:org_t)
- 2004
- 2004
- English.
- In: Current opinion in investigational drugs (London, England : 2000). - 1472-4472. ; 5:4, s. 456-62
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Palatin, under license from Competitive Technology, is developing the peptide PT-141, a synthetically modified analog of PT-14, as a nasal spray for the potential treatment of erectile dysfunction (ED) and female sexual dysfunction. In September 2003, Palatin had completed a phase IIb trial in patients with ED and in February 2004, Palatin planned to start phase III trials in early 2005.
Keyword
- MEDICINE
- MEDICIN
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Current opinion in investigational drugs (London, England : 2000) (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Hedlund, Petter
- Articles in the publication
- Current opinion ...
- By the university
- Linköping University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
